Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-08 7:55 pm Unchanged | 2024-05-08 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-12 5:35 pm Unchanged | 2024-04-12 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-04 4:39 pm Unchanged | 2024-04-04 | 13D | Enliven Therapeutics, Inc. ELVN | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-28 4:28 pm Unchanged | 2024-03-28 | 13D | Q32 Bio Inc. QTTB | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-22 4:59 pm Unchanged | 2024-03-22 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-21 4:31 pm Unchanged | 2024-03-21 | 13D | Adicet Bio, Inc. ACET | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-08 4:34 pm Unchanged | 2024-03-08 | 13D | NextCure, Inc. NXTC | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-21 4:11 pm Unchanged | 2024-02-21 | 13D | Kinnate Biopharma Inc. KNTE | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:45 pm Unchanged | 2024-02-14 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:41 pm Unchanged | 2024-02-14 | 13G | InspireMD, Inc. NSPR | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:36 pm Unchanged | 2024-02-14 | 13G | X4 Pharmaceuticals, Inc. XFOR | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:31 pm Unchanged | 2024-02-14 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:28 pm Unchanged | 2024-02-14 | 13G | SI-BONE, Inc. SIBN | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:21 pm Unchanged | 2024-02-14 | 13G | Scholar Rock Holding Corporation SRRK | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:11 pm Unchanged | 2024-02-14 | 13G | Protara Therapeutics, Inc. TARA | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 7:00 pm Unchanged | 2024-02-14 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 6:55 pm Unchanged | 2024-02-14 | 13G | Mersana Therapeutics, Inc. MRSN | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 6:51 pm Unchanged | 2024-02-14 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 6:47 pm Unchanged | 2024-02-14 | 13G | Kezar Life Sciences, Inc. KZR | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 6:42 pm Unchanged | 2024-02-14 | 13G | Elevation Oncology, Inc. ELEV | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |